Ormalin 60 Tablet contains Centchroman 60 mg, a selective estrogen receptor modulator (SERM) primarily used as a non-hormonal oral contraceptive and for the management of menstrual disorders. Centchroman acts by selectively modulating estrogen receptors in target tissues, thereby exerting anti-estrogenic effects on the uterus and breast while maintaining estrogenic activity in other tissues. This mechanism helps in preventing ovulation and altering the endometrial lining, contributing to its contraceptive efficacy. Ormalin 60 is indicated for the prevention of pregnancy in women seeking a non-steroidal contraceptive option, particularly those who may experience adverse effects with hormonal contraceptives. Additionally, it is utilized in the treatment of menorrhagia and dysmenorrhea due to its ability to regulate menstrual cycles and reduce excessive bleeding. The tablet is generally well tolerated, with side effects including mild gastrointestinal discomfort, headache, and occasional menstrual irregularities. It is contraindicated in patients with known hypersensitivity to Centchroman, liver dysfunction, or thromboembolic disorders. Ormalin 60 should be used under medical supervision with appropriate counseling regarding its contraceptive efficacy and potential side effects. Regular follow-up is recommended to monitor therapeutic response and ensure patient safety.